Slide Deck: Drug Pricing Bills
Allowing Medicare to directly negotiate the price of prescription drugs is a top priority for Democrats as lawmakers craft their budget reconciliation bill, though the details are still undetermined.
The House Energy and Commerce Committee held a hearing on drug pricing bills in May, including H.R. 3, a similar Medicare price negotiation bill to one the chamber passed in 2019, largely along party lines.
The previously passed price negotiation bill was estimated to save $456 billion over a decade, and Democrats want use these savings for their other health-care priorities, such as expanding Medicare coverage. The reconciliation process allows Democrats to pass legislation without Republican support, though there are limits on the types of provisions that can be included.
House and Senate committees have also considered more bipartisan efforts aimed at lowering drug prices by easing market entry for generic drugs, including a Senate Judiciary Committee mark up in July.
The attached presentation reviews bills related to Medicare price negotiations and generic drugs, as well as potential next steps in Congress.
Slide Deck: Democrats Eye Drug Pricing Changes in Budget Plan
Bloomberg
September 3, 2021 11:39 am
Slide Deck: Drug Pricing Bills
Allowing Medicare to directly negotiate the price of prescription drugs is a top priority for Democrats as lawmakers craft their budget reconciliation bill, though the details are still undetermined.
The House Energy and Commerce Committee held a hearing on drug pricing bills in May, including H.R. 3, a similar Medicare price negotiation bill to one the chamber passed in 2019, largely along party lines.
The previously passed price negotiation bill was estimated to save $456 billion over a decade, and Democrats want use these savings for their other health-care priorities, such as expanding Medicare coverage. The reconciliation process allows Democrats to pass legislation without Republican support, though there are limits on the types of provisions that can be included.
House and Senate committees have also considered more bipartisan efforts aimed at lowering drug prices by easing market entry for generic drugs, including a Senate Judiciary Committee mark up in July.
The attached presentation reviews bills related to Medicare price negotiations and generic drugs, as well as potential next steps in Congress.